Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HSK 21542

Next Previous
X
Search
Drug Profile

HSK 21542

Alternative Names: HSK-21542

Latest Information Update: 01 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sichuan Haisco Pharmaceutical
  • Class Antiemetics; Antipruritics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Postoperative pain
  • Phase II Pruritus
  • Clinical Phase Unknown Postoperative nausea and vomiting

Most Recent Events

  • 16 Sep 2024 First Affiliated Hospital of Wenzhou Medical University plans a phase II trial for Post operative nausea and vomiting in September 2024 (NCT06593782)
  • 04 Mar 2024 Xizang Haisco Pharmaceutical plans a phase II trial for Pruritus in March 2024 (PO, Tablet) (NCT06290375)
  • 10 Nov 2023 Clinical trials in Postoperative nausea and vomiting in China (IV) (NCT06170476)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top